Netherlands· NL-5fa8c053ec10

Lacidipine 2 mg Teva, filmomhulde tabletten

A lacidipine product containing lacidipine, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 7 of our 19 countries.

ATC C08CA09

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lacidipineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lacidipine is registered in 7 of 19 countries.

Countries holding a registration under ATC C08CA09 (lacidipine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
4 of them publish a price we can compare per daily dose

Search lacidipine products by name

Lacidipine · ATC C08CA09

7 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Italyprice
Netherlands
Polandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lacidipine costs, country by country.

Normalised to the WHO defined daily dose (4 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Lacidipine · price per daily dose (4 mg)

USD · FX 28 Sept 2026

IT Italy$0.37

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: LACIDIPINE
Manufacturer: Teva Nederland B.V.
Country: Netherlands (NL)
ATC code: C08CA09
ATC class: Lacidipine
Defined daily dose: 4 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
105980

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for lacidipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lacidipine against other medicines How interaction checks work

Lacidipine · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lacidipine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lacidipine products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

Bulgaria · Ласипил
Czechia · Lacipil
Denmark · Lacidipin Teva
Estonia · Lacipil, Prelum
Spain · Lacidipino Teva, Lacimen
United Kingdom (Northern Ireland) · Lacidipine Dr. Reddy's Laboratories (Uk), Lacidipine Generics [uk] Ltd
Greece · Lacipil
Croatia · Lacidipin Belupo, Lacipil
Hungary · Lacipil
Italy · Aponil, Lacidipina Doc Generici
Lithuania · Lacipil, Prelum
Latvia · Lacipil, Prelum
Malta · Lacidipine Doc Generici
Poland · Lacipil, Lacydyna
Portugal · Lacipil
Slovenia · Lacidipin Teva, Lacipil
Slovakia · Lacipil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/a2c94d45-c6f0-4132-8ac8-06222d4766b2
GET /v1/drugs/a2c94d45-c6f0-4132-8ac8-06222d4766b2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h105980_smpc.pdf",
  "strength": null,
  "atc_label": "Lacidipine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg105980",
  "excipients": [
    "ARABISCHE GOM (E 414)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 0-WATER",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 30 (E 1201)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "LACIDIPINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h105980.pdf",
  "authorised_at": "2011/02/24",
  "procedure_number": "NL/H/2974/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "105980",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about lacidipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console